<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T21:52:32Z</responseDate>
  <request identifier="oai:figshare.com:article/33940345" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33940345</identifier>
        <datestamp>2026-09-18T18:01:43Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_915</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_140</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Interface characteristics of the CPPF–TUBB3 &amp; CPPF–TUBA1B complex as identified by PDBePISA. PDBePISA analysis was conducted on ligand–protein complexes predicted by RFAA. The interface area, number of participating atoms and residues, solvent-accessible surface area, and Gibbs free energy ( G) were computed for both - and -subunits interacting with CPPF. Values in parentheses indicate the proportion relative to the total number of atoms or residues in the protein or ligand.&lt;/p&gt;</dc:title>
          <dc:creator>Jixin Yang (345976)</dc:creator>
          <dc:creator>Lisha Liang (16839548)</dc:creator>
          <dc:creator>Dengchao Zhu (25073614)</dc:creator>
          <dc:creator>Xuzhe Yin (25073617)</dc:creator>
          <dc:creator>Yizhuo Feng (25073620)</dc:creator>
          <dc:creator>Shaojun Tang (2546617)</dc:creator>
          <dc:creator>Muzi Li (698159)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Physical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Cardiology</dc:subject>
          <dc:subject>pyridinyl )- 2</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>&gt;&amp;# 946 ;&lt;/</dc:subject>
          <dc:subject>&gt;&amp;# 945 ;&lt;/</dc:subject>
          <dc:subject>5 -( 3</dc:subject>
          <dc:subject>targeting anticancer agent</dc:subject>
          <dc:subject>resistant cell lines</dc:subject>
          <dc:subject>plausible binding mode</dc:subject>
          <dc:subject>novel therapeutic drugs</dc:subject>
          <dc:subject>favorable binding energetics</dc:subject>
          <dc:subject>tubulin conformational state</dc:subject>
          <dc:subject>inhibit tubulin polymerization</dc:subject>
          <dc:subject>&gt;- tubulin contacts</dc:subject>
          <dc:subject>/- tubulin heterodimers</dc:subject>
          <dc:subject>cppf could suppress</dc:subject>
          <dc:subject>disrupt microtubule growth</dc:subject>
          <dc:subject>/- tubulin interface</dc:subject>
          <dc:subject>novel microtubule</dc:subject>
          <dc:subject>resistant cancers</dc:subject>
          <dc:subject>binding assays</dc:subject>
          <dc:subject>anticancer potential</dc:subject>
          <dc:subject>straight microtubule</dc:subject>
          <dc:subject>tubulin residues</dc:subject>
          <dc:subject>tubulin exhibited</dc:subject>
          <dc:subject>tubulin conformations</dc:subject>
          <dc:subject>cppf binding</dc:subject>
          <dc:subject>validated targets</dc:subject>
          <dc:subject>two major</dc:subject>
          <dc:subject>tumor efficacy</dc:subject>
          <dc:subject>taken together</dc:subject>
          <dc:subject>structural hypothesis</dc:subject>
          <dc:subject>results showed</dc:subject>
          <dc:subject>preserved across</dc:subject>
          <dc:subject>particularly val236</dc:subject>
          <dc:subject>often compromised</dc:subject>
          <dc:subject>monomer comparisons</dc:subject>
          <dc:subject>molecular dynamics</dc:subject>
          <dc:subject>mdr ).</dc:subject>
          <dc:subject>integrative ai</dc:subject>
          <dc:subject>fundamental mechanism</dc:subject>
          <dc:subject>findings establish</dc:subject>
          <dc:subject>experimental validation</dc:subject>
          <dc:subject>energy minima</dc:subject>
          <dc:subject>dominant contributions</dc:subject>
          <dc:subject>demonstrate anti</dc:subject>
          <dc:subject>comparable mm</dc:subject>
          <dc:subject>broader free</dc:subject>
          <dc:subject>animal models</dc:subject>
          <dc:description>&lt;p&gt;Interface characteristics of the CPPF–TUBB3 &amp; CPPF–TUBA1B complex as identified by PDBePISA. PDBePISA analysis was conducted on ligand–protein complexes predicted by RFAA. The interface area, number of participating atoms and residues, solvent-accessible surface area, and Gibbs free energy ( G) were computed for both - and -subunits interacting with CPPF. Values in parentheses indicate the proportion relative to the total number of atoms or residues in the protein or ligand.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T18:00:35Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pcbi.1014804.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Interface_characteristics_of_the_CPPF_TUBB3_CPPF_TUBA1B_complex_as_identified_by_PDBePISA_PDBePISA_analysis_was_conducted_on_ligand_protein_complexes_predicted_by_RFAA_The_interface_area_number_of_participating_atoms_and_residues_solvent/33940345</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
